NCT00133354 Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys Status COMPLETED Phase PHASE2/PHASE3
NCT00132158 ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00130975 Candesartan in the Prevention of Relapsing Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT00127829 Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic Status COMPLETED Phase PHASE1
NCT00126360 STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot) Status UNKNOWN Phase PHASE4
NCT00122356 Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment Status COMPLETED Phase PHASE3
NCT00122070 Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder Status COMPLETED Phase PHASE3
NCT00121667 Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone Status COMPLETED Phase PHASE3
NCT00121641 Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT00119626 Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Status COMPLETED Phase PHASE3
NCT00114816 Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer Status COMPLETED Phase PHASE3
NCT00114686 Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00114114 Dose-Response of Gonadal Steroids and Bone Turnover in Older Men Status COMPLETED Phase NA
NCT00112021 A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects Status COMPLETED Phase PHASE2
NCT00111540 Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00108823 The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121) Status COMPLETED Phase PHASE3
NCT00108004 Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3